Skip to main content
Log in

Update für die Hausarztpraxis

Vorhofflimmern früher erkennen, besser verstehen, erfolgreich behandeln

Atrial fibrillation - detect it earlier - understand it better - treat it effectively

  • FB_Schwerpunkt-Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Abstract:

Given its increasing prevalence, atrial fibrillation (AF) requires increasing attention from general practitioners, internists and cardiologists. It is therefore essential to provide information about the latest advances in AF treatment. The treatment strategy anchored in the guidelines along the CC-to-ABC scheme (Confirm, Characterize - to - Anticoagulation, Better Symptom Control, Comorbidities Management) should also include early rhythm control. Catheter ablation has been established as a safe and effective therapy for restoring and maintaining sinus rhythm. Several studies have shown its superiority over antiarrhythmic drug therapy. By rhythm control, catheter ablation has the potential to improve patients´ quality of live and left ventricular function, as well as reduce the risk of stroke. For selected patients, particularly those with heart failure, catheter ablation is the first-line treatment. Successful AF treatment requires a proactive approach. Thus, it is important to become familiar with the CC-to-ABC scheme, as well as catheter ablation, as effective strategies for treating AF and improve patient prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

© F. Straube

Abb. 3

© F. Straube

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Florian Straube.

Ethics declarations

F. S. hat Honorare für Vorträge von Medtronic, Boston Scientific, Philips, Bristol-Myers-Squibb und Astra Zeneca außerhalb der eingereichten Arbeit erhalten. L. R. hat Fortbildungsunterstützung von Boston Scientific und Biotronik erhalten. U. S. hat Honorare für Vorträge von Medtronic Inc., Bristol-Myers-Squibb und Astra Zeneca außerhalb der eingereichten Arbeit erhalten. E.F. ist Chefärztin der Abteilung und hat persönlich keine Konflikte anzugeben.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Straube, F., Riess, L., Dorwarth, U. et al. Vorhofflimmern früher erkennen, besser verstehen, erfolgreich behandeln. MMW Fortschr Med 166, 46–49 (2024). https://doi.org/10.1007/s15006-024-3612-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-024-3612-1

Keywords:

Navigation